STOCKSCREENR
Log In

0KHE.L

LSE

Revvity, Inc.

$88.87+2.88(+3.35%)Mkt Cap: $9.89B

Key Stats

Market Cap

$9.89B

P/E Ratio

14.42

EPS

$6.16

Dividend Yield

0.28%

52-Week Range

$79.50 — $138.90

Volume

5

Avg Volume

4.43K

Beta

1.11

Valuation

P/E (TTM)

14.42

Forward P/E

16.45

PEG Ratio

10.20

P/S (TTM)

3.91

P/B (TTM)

1.54

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.03%

ROA (TTM)

0.02%

ROIC

—

Gross Margin

0.50%

Operating Margin

0.13%

Net Margin

—

Debt/Equity

0.48

Current Ratio

1.68

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.16%

EPS Growth (5Y)

-0.13%

Sales Growth (3Y)

-0.04%

Sales Growth (5Y)

+0.03%

EPS Est (This Year)

$5.40

EPS Est (Next Year)

$5.98

Dividends

Dividend Yield

—

Annual Dividend

$0.07

Payout Ratio

—

Frequency

—

Ex-Dividend Date

2025-10-17

Cash/Share

$8.12

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

111.24M

Float

103.85M

Free Float %

93.36%

Technicals

RSI (14)

39.71

SMA 20

$97.11

SMA 50

$102.50

SMA 200

$95.88

ATR (14)

3.02

Volatility (Week)

0.03%

Volatility (Month)

0.03%

Pattern

—

Performance

1 Day

-1.98%

1 Week

-4.53%

1 Month

-9.94%

3 Months

-12.98%

6 Months

+7.26%

1 Year

—

YTD

-6.94%

All-Time High

$124.09

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

11000

CEO

Prahlad R. Singh

Index Membership

—

Website

https://www.perkinelmer.com

Revvity, Inc. (0KHE.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $9.89B, a P/E ratio of 14.42, and a dividend yield of 0.28%, 0KHE.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0KHE.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

LH

Labcorp Holdings Inc.

$270.62

+1.41%

$22.43B

ILMN

Illumina, Inc.

$120.84

+1.31%

$18.48B

NTRA

Natera, Inc.

$198.38

+0.35%

$28.12B

MEDP

Medpace Holdings, Inc.

$455.15

+0.33%

$12.92B

RDNT

RadNet, Inc.

$63.63

-0.73%

$4.94B

BLLN

BillionToOne, Inc.

$69.76

-2.21%

$3.20B

Frequently Asked Questions

What is Revvity, Inc.'s P/E ratio?

Revvity, Inc. (0KHE.L) has a trailing twelve-month (TTM) P/E ratio of 14.42. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Revvity, Inc. pay a dividend?

No, Revvity, Inc. (0KHE.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Revvity, Inc.'s market cap?

Revvity, Inc. (0KHE.L) has a market capitalization of $9.89 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0KHE.L performed this year?

Revvity, Inc. (0KHE.L) has returned -6.94% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.